MDT

96.72

-0.11%↓

A

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

A

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

A

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

A

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

A

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

Search

ResMed Inc

Fechado

SetorSaúde

257.58 -0.02

Visão Geral

Variação de preço das ações

24h

Atual

Mín

257.58

Máximo

257.58

Indicadores-chave

By Trading Economics

Rendimento

-31M

349M

Vendas

-12M

1.3B

P/E

Médio do Setor

26.391

90.831

Rendimento de Dividendos

0.87

Margem de lucro

26.096

Funcionários

10,600

EBITDA

-29M

503M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+14.14% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.87%

2.20%

Próximos Ganhos

29 de jan. de 2026

Próxima data de dividendos

19 de mar. de 2026

Próxima data de ex-dividendo

12 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-193M

38B

Abertura anterior

257.6

Fecho anterior

257.58

Sentimento de Notícias

By Acuity

27%

73%

78 / 361 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

19 de jan. de 2026, 16:17 UTC

Aquisições, Fusões, Aquisições de Empresas

Zurich Insurance Makes $10 Billion Bid for U.K. Specialist Insurer Beazley -- Update

19 de jan. de 2026, 23:50 UTC

Conversa de Mercado

Nikkei May Decline Amid Uncertainty Over U.S.-Europe Relations -- Market Talk

19 de jan. de 2026, 23:42 UTC

Conversa de Mercado

Gold Edges Lower on Likely Technical Correction -- Market Talk

19 de jan. de 2026, 22:29 UTC

Conversa de Mercado

China Infant Formula Market May Hold Up Despite Steep Drop in Births -- Market Talk

19 de jan. de 2026, 22:29 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

19 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

19 de jan. de 2026, 21:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

19 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

19 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

19 de jan. de 2026, 17:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

19 de jan. de 2026, 17:09 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

19 de jan. de 2026, 17:09 UTC

Conversa de Mercado

Copper Rises in Spite of Softer Dollar, Trade Concerns -- Market Talk

19 de jan. de 2026, 16:18 UTC

Conversa de Mercado

New Zealand Dollar Could Recover Against Swedish Krona -- Market Talk

19 de jan. de 2026, 16:12 UTC

Conversa de Mercado

Norwegian Krone's Recent Gains Are Unlikely to Last -- Market Talk

19 de jan. de 2026, 16:06 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: Deal Completion Subject to Customary Closing Conditions and Expected to Close in Around Two Months

19 de jan. de 2026, 16:04 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: Both Parties Aim to Set Up Strategic Cooperation in the Retail Sector

19 de jan. de 2026, 16:03 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH, CTG Duty-Free Also Entered Into a MoU

19 de jan. de 2026, 16:02 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: Subscription to Be Made Upon Completion of Transaction

19 de jan. de 2026, 16:00 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: Capital Increase by Subscribing to Newly Issued H-shares Listed in Hong Kong

19 de jan. de 2026, 16:00 UTC

Conversa de Mercado

Term Premium on U.S. Treasurys Looks Too Low, Says Pictet AM -- Market Talk

19 de jan. de 2026, 15:58 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH and the Miller Family Will Participate in a Capital Increase of CTG DutyFree

19 de jan. de 2026, 15:57 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: DFS Will Continue to Operate Its Other Luxury Travel Retail Operations Worldwide

19 de jan. de 2026, 15:57 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: Proceeds of Transaction Will Be Paid in Cash

19 de jan. de 2026, 15:56 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: CTG Duty-Free Will Run the Acquisition Through Its Subsidiary China Duty Free International Limited

19 de jan. de 2026, 15:53 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: Intangible Assets Include a Series of DFS Brands and IP for Exclusive Use in Greater China

19 de jan. de 2026, 15:52 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: CTG Duty-Free to Acquire the DFS Retail Stores in Hong Kong and Macau and Intangible Assets

19 de jan. de 2026, 15:51 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: DFS, CTG Duty-Free Reach Definitive Pact for CTG Duty-Free to Buy DFS' Travel Retail Unit in Hong Kong and Macau and Intangible Assets in Greater China

19 de jan. de 2026, 15:39 UTC

Conversa de Mercado

Canadian Dollar's Underperformance Looks Overstretched -- Market Talk

19 de jan. de 2026, 15:37 UTC

Conversa de Mercado

Bank of Canada Could Consider Cutting Rates if Underlying Inflation Slows Further -- Market Talk

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

14.14% parte superior

Previsão para 12 meses

Média 294 USD  14.14%

Máximo 345 USD

Mínimo 260 USD

Com base em 11 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

11 ratings

6

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

78 / 361 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat